Provided by Tiger Trade Technology Pte. Ltd.

Oric Pharmaceuticals Inc.

11.13
-0.0300-0.27%
Post-market: 11.130.00000.00%16:10 EDT
Volume:1.50M
Turnover:16.76M
Market Cap:1.12B
PE:-7.57
High:11.62
Open:11.22
Low:10.59
Close:11.16
52wk High:14.93
52wk Low:3.90
Shares:100.36M
Float Shares:86.55M
Volume Ratio:0.89
T/O Rate:1.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4700
EPS(LYR):-1.4747
ROE:-41.27%
ROA:-26.17%
PB:2.91
PE(LYR):-7.55

Loading ...

ORIC Pharmaceuticals Q4 loss narrows

Reuters
·
Feb 24

ORIC Q4 net loss USD 30.51 million, R&D expenses USD 25.86 million -19%

Reuters
·
Feb 24

BRIEF-ORIC Pharmaceuticals Q4 Net Income USD -30.505 Million

Reuters
·
Feb 24

Oric Pharmaceuticals Q4 Operating Expenses USD 34.551 Million

THOMSON REUTERS
·
Feb 24

ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Updates

GlobeNewswire
·
Feb 24

Oric Pharmaceuticals Grants Stock Options and Restricted Stock Units to New Employees

Reuters
·
Feb 07

Oric Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Feb 07

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Feb 07

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Feb 06

Oric Pharmaceuticals Director Richard A. Heyman Reports Sale of Common Shares

Reuters
·
Jan 21

ORIC Pharmaceuticals: Dense Near‑Term Clinical Catalysts and Encouraging Efficacy Data Underpin Reiterated Buy Rating

TIPRANKS
·
Jan 15

Wedbush Sticks to Their Buy Rating for Oric Pharmaceuticals (ORIC)

TIPRANKS
·
Jan 13

Oric Pharmaceuticals Price Target Maintained With a $20.00/Share by Wedbush

Dow Jones
·
Jan 13

Oric Pharmaceuticals Raises $244 Million in Private Placement

Reuters
·
Jan 12

Oric Pharmaceuticals Appoints Kevin Brodbeck as Chief Technical Officer

Reuters
·
Jan 12

ORIC® Pharmaceuticals Provides Operational Highlights for 2025 and Anticipated Upcoming Milestones

GlobeNewswire
·
Jan 12

Oric Pharmaceuticals Initiated at Overweight by Piper Sandler

Dow Jones
·
Jan 07

Piper Sandler Initiates ORIC Pharmaceuticals Inc at Overweight With $22 Price Target

MT Newswires Live
·
Jan 07

ORIC® Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire
·
Jan 07

BUZZ-India's Orient Technologies rises after shareholders approve bonus issue

Reuters
·
Dec 30, 2025